Seung Chu

Person

Cypress, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterodimeric antibodies that bind fibroblast activation protein
- Patent number 12,180,302
- Issue date Dec 31, 2024
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 12,129,309
- Issue date Oct 29, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,945,880
- Issue date Apr 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,859,011
- Issue date Jan 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies that bind to CD38 and CD3
- Patent number 11,840,579
- Issue date Dec 12, 2023
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CLDN6
- Patent number 11,739,144
- Issue date Aug 29, 2023
- Xencor, Inc.
- Matthew S. Faber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,673,972
- Issue date Jun 13, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and PSMA
- Patent number 11,623,957
- Issue date Apr 11, 2023
- Xencor, Inc.
- Gregory Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized antibodies that target CD19
- Patent number 11,618,788
- Issue date Apr 4, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 11,566,080
- Issue date Jan 31, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind ENPP3 and CD3
- Patent number 11,472,890
- Issue date Oct 18, 2022
- Xencor, Inc.
- Rumana Rashid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for inhibiting CD32B expressing cells
- Patent number 11,447,552
- Issue date Sep 20, 2022
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting CD32B expressing cells
- Patent number 11,434,295
- Issue date Sep 6, 2022
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 11,352,442
- Issue date Jun 7, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,225,528
- Issue date Jan 18, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,111,315
- Issue date Sep 7, 2021
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulation of T cells with bispecific antibodies and Fc fusions
- Patent number 11,091,548
- Issue date Aug 17, 2021
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind fibroblast activation protein
- Patent number 10,982,006
- Issue date Apr 20, 2021
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 10,913,803
- Issue date Feb 9, 2021
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 10,889,653
- Issue date Jan 12, 2021
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies that bind to CD38 and CD3
- Patent number 10,858,451
- Issue date Dec 8, 2020
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Optimized antibodies that target CD19
- Patent number 10,626,182
- Issue date Apr 21, 2020
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeting regulatory T cells with heterodimeric proteins
- Patent number 10,544,187
- Issue date Jan 28, 2020
- Xencor, Inc.
- Seung Chu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 10,526,417
- Issue date Jan 7, 2020
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting regulatory T cells with heterodimeric proteins
- Patent number 10,519,242
- Issue date Dec 31, 2019
- Xencor, Inc.
- Seung Chu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trispecific antibodies
- Patent number 10,428,155
- Issue date Oct 1, 2019
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 10,259,887
- Issue date Apr 16, 2019
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and PSMA
- Patent number 10,227,410
- Issue date Mar 12, 2019
- Xencor, Inc.
- Gregory Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulation of T cells with bispecific antibodies and FC fusions
- Patent number 10,227,411
- Issue date Mar 12, 2019
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting CD32B expressing cells
- Patent number 9,914,778
- Issue date Mar 13, 2018
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240400675
- Publication date Dec 5, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TSLPR (CRLF2) ANTIBODIES
- Publication number 20240360233
- Publication date Oct 31, 2024
- Board of Regents, The University of Texas System
- Dongxing ZHA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240228608
- Publication date Jul 11, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240132584
- Publication date Apr 25, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20230365717
- Publication date Nov 16, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODIES THAT TARGET CD19
- Publication number 20230340144
- Publication date Oct 26, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20230272114
- Publication date Aug 31, 2023
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3
- Publication number 20230227581
- Publication date Jul 20, 2023
- Xencor, Inc.
- Rumana Rashid
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN I...
- Publication number 20230227560
- Publication date Jul 20, 2023
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRISPECIFIC ANTIBODIES
- Publication number 20230086017
- Publication date Mar 23, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
- Publication number 20220403049
- Publication date Dec 22, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20220289839
- Publication date Sep 15, 2022
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20220162343
- Publication date May 26, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20220041757
- Publication date Feb 10, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
- Publication number 20210395363
- Publication date Dec 23, 2021
- Xencor, Inc.
- Seung Yup Chu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Antibodies That Bind to CD38 and CD3
- Publication number 20210309762
- Publication date Oct 7, 2021
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN
- Publication number 20210253736
- Publication date Aug 19, 2021
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20210102003
- Publication date Apr 8, 2021
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
- Publication number 20210009689
- Publication date Jan 14, 2021
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
- Publication number 20210009690
- Publication date Jan 14, 2021
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS
- Publication number 20200339624
- Publication date Oct 29, 2020
- Xencor, Inc.
- Seung Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20200332024
- Publication date Oct 22, 2020
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODIES THAT TARGET CD19
- Publication number 20200317804
- Publication date Oct 8, 2020
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3
- Publication number 20200317814
- Publication date Oct 8, 2020
- Xencor, Inc.
- Rumana Rashid
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND PSMA
- Publication number 20200216559
- Publication date Jul 9, 2020
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
- Publication number 20200199251
- Publication date Jun 25, 2020
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN
- Publication number 20200165356
- Publication date May 28, 2020
- Xencor, Inc.
- John Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
- Publication number 20200071402
- Publication date Mar 5, 2020
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRISPECIFIC ANTIBODIES
- Publication number 20190352416
- Publication date Nov 21, 2019
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
- Publication number 20190330342
- Publication date Oct 31, 2019
- Xencor, Inc.
- Seung Yup Chu
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Heterodimeric antibodies that bind fibroblast activation protein

Heterodimeric antibodies that bind CD3 and CD38

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and tumor antigens

Bispecific antibodies that bind to CD38 and CD3

Heterodimeric antibodies that bind CD3 and CLDN6

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and PSMA

Optimized antibodies that target CD19

Compositions and methods for treating IgE-mediated disorders

Heterodimeric antibodies that bind ENPP3 and CD3

Methods and compositions for inhibiting CD32B expressing cells

Methods and compositions for inhibiting CD32B expressing cells

Heterodimeric antibodies that bind CD3 and CD38

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and tumor antigens

Modulation of T cells with bispecific antibodies and Fc fusions

Heterodimeric antibodies that bind fibroblast activation protein

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and tumor antigens

Bispecific antibodies that bind to CD38 and CD3

Optimized antibodies that target CD19

Targeting regulatory T cells with heterodimeric proteins

Heterodimeric antibodies that bind CD3 and CD38

Targeting regulatory T cells with heterodimeric proteins

Trispecific antibodies

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and PSMA

Modulation of T cells with bispecific antibodies and FC fusions

Methods and compositions for inhibiting CD32B expressing cells

Patents Applicationslast 30 patents

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

ANTI-TSLPR (CRLF2) ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

OPTIMIZED ANTIBODIES THAT TARGET CD19

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN I...

TRISPECIFIC ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Bispecific Antibodies That Bind to CD38 and CD3

HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

OPTIMIZED ANTIBODIES THAT TARGET CD19

HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND PSMA

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

TRISPECIFIC ANTIBODIES

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS